Locomotor Experience Applied Post Stroke Trial
LEAPS
2 other identifiers
interventional
408
1 country
8
Brief Summary
The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 stroke
Started Apr 2006
Longer than P75 for phase_3 stroke
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2005
CompletedFirst Posted
Study publicly available on registry
October 25, 2005
CompletedStudy Start
First participant enrolled
April 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedResults Posted
Study results publicly available
September 22, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedJuly 16, 2014
December 1, 2012
4 years
October 24, 2005
March 29, 2011
July 9, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke
Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.
12 months post-stroke
Walking Speed: Measured During a 10-meter Walk
Baseline and 12 months post-stroke
Secondary Outcomes (10)
Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke
Baseline and 6 months post-stroke
6 Month Outcome: Walking Speed: Measured During a 10-meter Walk
Baseline and 6 months post-stroke
6 Minute Walking Distance (Meters)
Baseline, 6 months and 12 months post-stroke
Step Activity Monitor (SAM)- Median of Average Number of Steps Per Day
Baseline, 6 months and 12 months post-stroke
Stroke Impact Scale (SIS) - Participation
Baseline, 6 months and 12 months post-stroke
- +5 more secondary outcomes
Study Arms (3)
Early Locomotor Training Program
ACTIVE COMPARATORbody weight supported training program with treadmill
Late Locomotor Training Program
ACTIVE COMPARATORbody weight supported training program with treadmill
Early Home Exercise Program
ACTIVE COMPARATORa non-specific low intensity exercise program
Interventions
The early locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 2 months post-stroke.
The late locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 6 months post-stroke.
Participants in the early home exercise group will receive a non-specific low intensity exercise program beginning at 2 months post stroke.
Eligibility Criteria
You may qualify if:
- Age \>/=18
- Stroke within 45-days
- Residual paresis in the lower extremity (fugl-meyer le motor score \< 34)
- Ability to sit unsupported for 30 seconds
- Ability to walk at least 10 feet with maximum 1 person assist
- Ability to follow a three step command
- Provision of informed consent
- A self-selected 10 meter gait speed less than 0.8 m/s at the 2-month post-stroke assessment
- Successful completion of an exercise tolerance test
You may not qualify if:
- Lived in nursing home prior to stroke
- Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking less than 200 meters
- Serious cardiac conditions (history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living). Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded
- History of serious chronic obstructive pulmonary disease or oxygen dependence
- Severe weight bearing pain
- Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia, or previous stroke with residual neurological deficits
- History of major head trauma
- Lower extremity amputation
- Non-healing ulcers on the lower extremity
- Renal dialysis or end stage liver disease
- Legal blindness or severe visual impairment
- A history of significant psychiatric illness defined by diagnosis of bipolar affective disorder, psychosis, schizophrenia or medication refractory depression
- Life expectancy less than one year
- Severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion (ROM) \< 90°, hip flexion contracture \> 25°, and ankle plantar flexion contracture \> 15°
- History of sustained alcoholism or drug abuse in the last six months
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Centinela Freeman Memorial Hospital
Inglewood, California, United States
Long Beach Memorial Hospital
Long Beach, California, United States
University of Southern California - PT Associates
Los Angeles, California, United States
Sharp Memorial Rehabilitation Center
San Diego, California, United States
University of Florida
Gainesville, Florida, United States
Brooks Rehabilitation Hospital
Jacksonville, Florida, United States
Florida Hospital
Orlando, Florida, United States
Duke University (Administrative Coordinating Center)
Durham, North Carolina, United States
Related Publications (6)
Seamon BA, Kautz SA, Velozo CA. Measurement Precision and Efficiency of Computerized Adaptive Testing for the Activities-specific Balance Confidence Scale in People With Stroke. Phys Ther. 2021 Apr 4;101(4):pzab020. doi: 10.1093/ptj/pzab020.
PMID: 33481989DERIVEDNadeau SE, Dobkin B, Wu SS, Pei Q, Duncan PW; LEAPS Investigative Team. The Effects of Stroke Type, Locus, and Extent on Long-Term Outcome of Gait Rehabilitation: The LEAPS Experience. Neurorehabil Neural Repair. 2016 Aug;30(7):615-25. doi: 10.1177/1545968315613851. Epub 2015 Oct 23.
PMID: 26498434DERIVEDNadeau SE, Wu SS, Dobkin BH, Azen SP, Rose DK, Tilson JK, Cen SY, Duncan PW; LEAPS Investigative Team. Effects of task-specific and impairment-based training compared with usual care on functional walking ability after inpatient stroke rehabilitation: LEAPS Trial. Neurorehabil Neural Repair. 2013 May;27(4):370-80. doi: 10.1177/1545968313481284. Epub 2013 Mar 15.
PMID: 23504552DERIVEDTilson JK, Wu SS, Cen SY, Feng Q, Rose DR, Behrman AL, Azen SP, Duncan PW. Characterizing and identifying risk for falls in the LEAPS study: a randomized clinical trial of interventions to improve walking poststroke. Stroke. 2012 Feb;43(2):446-52. doi: 10.1161/STROKEAHA.111.636258. Epub 2012 Jan 12.
PMID: 22246687DERIVEDDuncan PW, Sullivan KJ, Behrman AL, Azen SP, Wu SS, Nadeau SE, Dobkin BH, Rose DK, Tilson JK, Cen S, Hayden SK; LEAPS Investigative Team. Body-weight-supported treadmill rehabilitation after stroke. N Engl J Med. 2011 May 26;364(21):2026-36. doi: 10.1056/NEJMoa1010790.
PMID: 21612471DERIVEDDuncan PW, Sullivan KJ, Behrman AL, Azen SP, Wu SS, Nadeau SE, Dobkin BH, Rose DK, Tilson JK; LEAPS Investigative Team. Protocol for the Locomotor Experience Applied Post-stroke (LEAPS) trial: a randomized controlled trial. BMC Neurol. 2007 Nov 8;7:39. doi: 10.1186/1471-2377-7-39.
PMID: 17996052DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Pamela W. Duncan, PT, PhD, FAHA, FAPTA
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Pamela W. Duncan, PhD, PT, FAPTA, FAHA
Professor and Bette Busch Maniscalco, Doctor of Physical Therapy Division, Research Fellow, Department of Community and Family Medicine, Duke Center for Clinical Health Policy Research
- PRINCIPAL INVESTIGATOR
Katherine J. Sullivan, Ph.D., PT
Co-Principal Investigator, Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California
- PRINCIPAL INVESTIGATOR
Andrea L. Behrman, Ph.D., PT
Co-Principal Investigator, Department of Physical Therapy, Brooks Center for Rehabilitation Studies, University of Florida, and Department of Veteran Affairs Brain Rehabilitation Research Center, Gainesville, Florida
- STUDY DIRECTOR
Stanley P. Azen, Ph.D.,
Director Data Management Core, Biostatistics Division, Department of Preventive Medicine, University of Southern California, Los Angeles, California
- STUDY DIRECTOR
Samuel S. Wu, Ph.D.
Lead Biostatistician - Investigator, Department of Epidemiology and Health Policy Research, University of Florida
- STUDY DIRECTOR
Bruce H. Dobkin, MD
Investigator, Department of Neurology, University of California, Los Angeles, California
- STUDY DIRECTOR
Stephen E. Nadeau, MD
Investigator, Geriatric Research, Education and Clinical Center and the Brain Rehabilitation Research Center, Gainesville VA Medical Center, and the Department of Neurology, University of Florida College of Medicine, Gainesville, Fl
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2005
First Posted
October 25, 2005
Study Start
April 1, 2006
Primary Completion
April 1, 2010
Study Completion
June 1, 2012
Last Updated
July 16, 2014
Results First Posted
September 22, 2011
Record last verified: 2012-12